Merline Saintil, a director at Rocket Lab USA Inc. (RKLB), reported selling 10,000 shares of common stock on December 4, 2025, at $48 per share, for a total transaction value of $480,000. Following the sale, her direct beneficial ownership stands at 413,529 shares. The Form 4 filing on December 5, 2025, does not check the box indicating a Rule 10b5-1 trading plan, implying a discretionary open-market sale. No derivative transactions were reported, and no historical pattern or context (e.g., prior trades, earnings timing) is provided in the filing.

This small discretionary sale by a director signals moderate bearish insider confidence, potentially indicating profit-taking at elevated prices, though she retains substantial holdings suggesting limited conviction to fully exit.